How much profit has Merck & Co made this year?
Merck & Co has made 21.94 B USD this year.
Merck & Co Net Income 2024
Merck & Co Net Income
21.94 B USD
Merck & Co Dividend yield
2.26 %
Ticker
MRK
ISIN
US58933Y1055
WKN
A0YD8Q
In 2024, Merck & Co's profit amounted to 21.94 B USD, a 5,910.52% increase from the 365 M USD profit recorded in the previous year.
The Merck & Co Net Income history
| YEAR | NET INCOME (undefined USD) |
|---|---|
| 2029e | 27.15 |
| 2028e | 29.56 |
| 2027e | 28.24 |
| 2026e | 27.57 |
| 2025e | 25.01 |
| 2024e | 21.94 |
| 2023 | 0.37 |
| 2022 | 14.52 |
| 2021 | 13.05 |
| 2020 | 7.07 |
| 2019 | 9.84 |
| 2018 | 6.22 |
| 2017 | 2.39 |
| 2016 | 3.92 |
| 2015 | 4.44 |
| 2014 | 11.92 |
| 2013 | 4.4 |
| 2012 | 6.17 |
| 2011 | 6.26 |
| 2010 | 0.86 |
| 2009 | 12.85 |
| 2008 | 7.79 |
| 2007 | 3.27 |
| 2006 | 4.43 |
| 2005 | 4.63 |
| 2004 | 5.83 |
Merck & Co Aktienanalyse
What does Merck & Co do?
The company Merck & Co Inc has a long history. It was founded in 1891 by the German pharmacist Friedrich Jacob Merck and is now based in Kenilworth, New Jersey, USA. The company has evolved over time into a globally operating company in the pharmaceutical and chemical industry. Merck & Co Inc's business model is based on the development, production, and marketing of medicines and products for the healthcare industry. The company collaborates with other partners such as universities, other companies, and governments to achieve the best possible scientific progress. Research and development play a very important role in this. Merck is divided into three main areas: The Human Health division, which specializes in the development of prescription drugs and products to improve human health. The second division is Animal Health, which focuses on animal medicines and care products. The third division, Life Science (formerly MilliporeSigma), is dedicated to the development of products and services for biopharmaceutical research and production to facilitate the discovery and manufacturing of medicines. Merck & Co Inc. offers a wide range of products, ranging from prescription medicines to specialty chemicals. Some of the most well-known drugs include Januvia for the treatment of type 2 diabetes and Keytruda, an immuno-oncology drug used in the treatment of various types of cancer. Other well-known drugs from Merck & Co Inc. include Gardasil for the prevention of HPV infections, Propecia for the treatment of male pattern hair loss, and Zetia for the treatment of high cholesterol. The company is extremely innovative and has made significant advances in pharmaceutical research in recent decades. Merck & Co Inc. has won numerous awards over the years, including the "2018 Australian Financial Review Boss Most Innovative Companies Award" and the "2018 Global Energy Award for Technology Innovation". Merck & Co Inc. operates worldwide and has subsidiaries and partnerships in many countries. The company has about 69,000 employees and distributes its products in over 140 countries. Merck & Co Inc.'s products are typically prescription-only and prescribed by doctors and professionals. Overall, Merck & Co Inc. is a company with an impressive history that is now one of the leading companies in the pharmaceutical and chemical industry. Thanks to its innovation and its consistent focus on the needs of patients and healthcare professionals, it is able to successfully meet challenges in the healthcare industry and set new standards. Merck & Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.Net Income Details
Understanding Merck & Co's Profit Margins
The profit margins of Merck & Co represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Merck & Co's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Year-to-Year Comparison
Evaluating Merck & Co's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Impact on Investments
Merck & Co's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
Interpreting Profit Fluctuations
When Merck & Co’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Frequently Asked Questions about Merck & Co Stock
How has the profit developed compared to last year?
The profit has increased by 5,910.52% compared to last year increased
What impact do the earnings have on the shareholders?
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
How does Merck & Co publish its earnings?
Merck & Co publishes its earnings in the form of quarterly or annual reports.
Which financial indicators are included in the quarterly or annual reports?
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
Why is it important for investors to know the earnings of Merck & Co?
The profits of Merck & Co are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
How can one learn more about the earnings of Merck & Co?
You can learn more about the earnings of Merck & Co by reviewing the quarterly or annual reports or following the company presentations.
How much dividend does Merck & Co pay?
Over the past 12 months, Merck & Co paid a dividend of 2.96 USD . This corresponds to a dividend yield of about 2.26 %. For the coming 12 months, Merck & Co is expected to pay a dividend of 3.37 USD.
What is the dividend yield of Merck & Co?
The current dividend yield of Merck & Co is 2.26 %.
When does Merck & Co pay dividends?
Merck & Co pays a quarterly dividend. This is distributed in the months of July, October, January, April.
How secure is the dividend of Merck & Co?
Merck & Co paid dividends every year for the past 26 years.
What is the dividend of Merck & Co?
For the upcoming 12 months, dividends amounting to 3.37 USD are expected. This corresponds to a dividend yield of 2.57 %.
In which sector is Merck & Co located?
Merck & Co is assigned to the 'Health' sector.
Wann musste ich die Aktien von Merck & Co kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Merck & Co from 4/5/2024 amounting to 0.77 USD, you needed to have the stock in your portfolio before the ex-date on 3/14/2024.
When did Merck & Co pay the last dividend?
The last dividend was paid out on 4/5/2024.
What was the dividend of Merck & Co in the year 2023?
In the year 2023, Merck & Co distributed 2.8 USD as dividends.
In which currency does Merck & Co pay out the dividend?
The dividends of Merck & Co are distributed in USD.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Merck & Co stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank
Andere Kennzahlen von Merck & Co
Our stock analysis for Merck & Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Merck & Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
